TABLE OF CONTENTS
1 MARKET INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE
2 RESEARCH METHODOLOGY
2.1 OVERVIEW
2.2 DATA FLOW
2.2.1 DATA MINING PROCESS
2.3 PURCHASED DATABASE:
2.4 SECONDARY SOURCES:
2.4.1 SECONDARY RESEARCH DATA FLOW:
2.5 PRIMARY RESEARCH:
2.5.1 PRIMARY RESEARCH DATA FLOW:
2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
2.6.1 REVENUE ANALYSIS APPROACH
2.7 DATA FORECASTING
2.7.1 DATA FORECASTING TECHNIQUE
2.8 DATA MODELLING
2.8.1 MICROECONOMIC FACTOR ANALYSIS:
2.8.2 DATA MOLDELLING:
2.9 TEAMS AND ANALYST CONTRIBUTION
3 MARKET DYNAMICS
3.1 INTRODUCTION
3.2 DRIVERS
3.2.1 RISING PREVALENCE OF TYPE 2 DIABETES
3.2.2 INCREASED PREVALENCE OF THALASSEMIA AND SICKLE CELL AMONG INDIA
3.3 RESTRAINTS
3.3.1 HIGH COST OF HBA1C TESTING
3.4 OPPORTUNITY
3.4.1 GROWING GERIATRIC POPULATION
4 MARKET FACTOR ANALYSIS
4.1 PORTER'S FIVE FORCES MODEL
4.1.1 THREAT OF NEW ENTRANTS
4.1.2 BARGAINING POWER OF SUPPLIERS
4.1.3 THREAT OF SUBSTITUTES
4.1.4 BARGAINING POWER OF BUYERS
4.1.5 INTENSITY OF RIVALRY
4.2 IMPACT OF COVID-19 ON THE INDIA HBA1C TESTING MARKET
4.3 REGULATORY LANDSCAPE BY INDIA
4.4 QUALITATIVE DATA ON NEW MEDTECH POLICES IN INDIA
4.5 OVERVIEW ON ISSUES EXPECTED FOR MAKE IN INDIA POLICES FORM TENDERS
4.6 CURRENT TRENDS IN THE INDIA HBA1C TESTING MARKET
4.7 QUALITATIVE DATA ON OPPORTUNITY FOR SELLING DIAGNOSTICS EQUIPMENTS FOR THE CLIENTS
5 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 REAGENTS & KITS
5.3 INSTRUMENTS
5.3.1 BENCH TOP DEVICES
5.3.2 HAND-HELD DEVICES
5.4 INSTRUMENTS
6 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 ION-EXCHANGE HPLC
6.3 IMMUNOASSAY
6.4 BORONATE AFFINITY HPLC
6.5 ENZYMATIC ASSAY
6.6 TURBIDIMETRIC INHIBITION IMMUNOASSAY (TINIA)
6.7 OTHERS
7 INDIA HBA1C TESTING MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 THALASSEMIA
7.3 SICKLE CELL ANAEMIA
7.4 TYPE 2 DIABETES
8 INDIA HBA1C TESTING MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS AND CLINICS
8.3 DIAGNOSTIC LABORATORIES
8.4 OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS, 2022
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
9.6.1 PRODUCT LAUNCH
9.6.2 COLLABORATION
10 COMPANY PROFILES
10.1 SIEMENS HEALTHINEERS AG
10.1.1 COMPANY OVERVIEW
10.1.2 FINANCIAL OVERVIEW
10.1.3 PRODUCTS OFFERED
10.1.4 KEY DEVELOPMENTS
10.1.5 SWOT ANALYSIS
10.1.6 KEY STRATEGIES
10.2 PTS DIAGNOSTICS
10.2.1 COMPANY OVERVIEW
10.2.2 FINANCIAL OVERVIEW
10.2.3 PRODUCTS OFFERED
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIES
10.3 ARKRAY, INC
10.3.1 COMPANY OVERVIEW
10.3.2 FINANCIAL OVERVIEW
10.3.3 PRODUCTS OFFERED
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIES
10.4 F. HOFFMANN-LA ROCHE LTD
10.4.1 COMPANY OVERVIEW
10.4.2 FINANCIAL OVERVIEW
10.4.3 PRODUCTS OFFERED
10.4.4 KEY DEVELOPMENTS
10.4.5 SWOT ANALYSIS
10.4.6 KEY STRATEGIES
10.5 BECKMAN COULTER, INC.
10.5.1 COMPANY OVERVIEW
10.5.2 FINANCIAL OVERVIEW
10.5.3 PRODUCTS OFFERED
10.5.4 KEY DEVELOPMENTS
10.5.5 SWOT ANALYSIS
10.5.6 KEY STRATEGIES
10.6 LUMIRADX
10.6.1 COMPANY OVERVIEW
10.6.2 FINANCIAL OVERVIEW
10.6.3 PRODUCTS OFFERED
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIES
10.7 ABBOTT
10.7.1 COMPANY OVERVIEW
10.7.2 FINANCIAL OVERVIEW
10.7.3 PRODUCTS OFFERED
10.7.4 KEY DEVELOPMENTS
10.7.5 SWOT ANALYSIS
10.7.6 KEY STRATEGIES
10.8 BIO-RAD LABORATORIES, INC.
10.8.1 COMPANY OVERVIEW
10.8.2 FINANCIAL OVERVIEW
10.8.3 PRODUCTS OFFERED
10.8.4 KEY DEVELOPMENTS
10.8.5 SWOT ANALYSIS
10.8.6 KEY STRATEGIES
10.9 TRANSASIA BIO-MEDICALS
10.9.1 COMPANY OVERVIEW
10.9.2 FINANCIAL OVERVIEW
10.9.3 PRODUCTS OFFERED
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIES
10.10 HEMOCUE AB
10.10.1 COMPANY OVERVIEW
10.10.2 FINANCIAL OVERVIEW
10.10.3 PRODUCTS OFFERED
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIES
11 DATA CITATIONS
LIST OF TABLES
TABLE 1 QFD MOLDELLING FOR MARKET SHARE ASSESSMENT
TABLE 2 REGULATORY LANDSCAPE BY INDIA
TABLE 3 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2019–2032 (USD BILLION)
TABLE 4 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2019–2032 (UNITS)
TABLE 5 INDIA HBA1C TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2019–2032 (USD BILLION)
TABLE 6 INDIA HBA1C TESTING MARKET, FOR INSTRUMENTS, BY TYPE, 2019–2032 (UNITS)
TABLE 7 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY, 2019–2032 (USD BILLION)
TABLE 8 INDIA HBA1C TESTING MARKET, BY APPLICATION, 2019–2032 (USD BILLION)
TABLE 9 INDIA HBA1C TESTING MARKET, BY END USER, 2019–2032 (USD BILLION)
TABLE 10 INDIA HBA1C TESTING MARKET, FOR HOSPITALS, BY PRODUCT TYPE, 2019–2032 (UNITS)
TABLE 11 INDIA HBA1C TESTING MARKET, FOR GOVERNMENT HOSPITALS, BY PRODUCT TYPE, 2019–2032 (UNITS)
TABLE 12 INDIA HBA1C TESTING MARKET, FOR PRIVATE HOSPITALS, BY PRODUCT TYPE, 2019–2032 (UNITS)
TABLE 13 PUBLIC PLAYERS STOCK SUMMARY
TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 15 PRODUCT LAUNCH
TABLE 16 COLLABORATION
TABLE 17 SIEMENS HEALTHINEERS AG: PRODUCT OFFERED
TABLE 18 PTS DIAGNOSTICS: PRODUCT OFFERED
TABLE 19 PTS DIAGNOSTICS: KEY DEVELOPMENTS
TABLE 20 ARKRAY, INCPRODUCT OFFERED
TABLE 21 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED
TABLE 22 BECKMAN COULTER INC.: PRODUCTS OFFERED
TABLE 23 LUMIRADX: PRODUCTS OFFERED
TABLE 24 ABBOTT: PRODUCTS OFFERED
TABLE 25 ABBOTT: KEY DEVELOPMENTS
TABLE 26 BIO-RAD LABORATORIES, INC.: PRODCUTS OFFERED
TABLE 27 TRANSASIA BIO-MEDICALS: PRODUCTS OFFERED
TABLE 28 HEMOCUE AB: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 INDIA HBA1C TESTING MARKET: STRUCTURE
FIGURE 2 INDIA HBA1C MARKET REPORT: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: INDIA HBA1C TESTING MARKET
FIGURE 6 INDIA HBA1C TESTING MARKET, PRODUCT TYPE SEGMENT ATTRACTIVENESS, 2022-2032 (USD BILLION)
FIGURE 7 INDIA HBA1C TESTING MARKET, BY PRODUCT TYPE, 2022 & 2032 (USD BILLION)
FIGURE 8 INDIA HBA1C TESTING MARKET SHARE (%), BY PRODUCT TYPE, 2022
FIGURE 9 INDIA HBA1C TESTING MARKET, TECHNOLOGY SEGMENT ATTRACTIVENESS, 2022-2032 (USD BILLION)
FIGURE 10 INDIA HBA1C TESTING MARKET, BY TECHNOLOGY, 2022 & 2032 (USD BILLION)
FIGURE 11 INDIA HBA1C TESTING MARKET SHARE (%), BY TECHNOLOGY, 2022
FIGURE 12 INDIA HBA1C TESTING MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2022-2032 (USD BILLION)
FIGURE 13 INDIA HBA1C TESTING MARKET, BY APPLICATION, 2022 & 2032 (USD BILLION)
FIGURE 14 INDIA HBA1C TESTING MARKET SHARE (%), BY APPLICATION, 2022
FIGURE 15 INDIA HBA1C TESTING MARKET, END USER SEGMENT ATTRACTIVENESS, 2022-2032 (USD BILLION)
FIGURE 16 INDIA HBA1C TESTING MARKET, BY END USER, 2022 & 2032 (USD BILLION)
FIGURE 17 INDIA HBA1C TESTING MARKET SHARE (%), BY END USER, 2022
FIGURE 18 INDIA HBA1C TESTING MARKET PLAYERS: COMPETITIVE ANALSIS, 2022
FIGURE 19 COMPETITOR DASHBOARD: INDIA HBA1C TESTING MARKET
FIGURE 20 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
FIGURE 22 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 24 BECKMAN COULTER INC.: SWOT ANALYSIS
FIGURE 25 LUMIRADX: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 ABBOTT: FINANCIAL OVERVIEW
FIGURE 27 ABBOTT: SWOT ANALYSIS
FIGURE 28 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW
FIGURE 29 BIO-RAD LABORATORIES, INC: SWOT ANALYSIS
